SDIC Fund Management-invested Zylox-Tonbridge Medical Technology Co., Ltd. was successfully listed on HKEx on July 5th, 2021, coded 2190.HK.

Zylox Tonbridge Medical Technology Co., Ltd. is a leading producer of interventional medical devices for nerves and peripheral blood vessels in China. Since its establishment in 2012, the company has developed 45 high quality products. At present, the company has 39 new products under research and development.

SDIC Fund Management and SDIC Investment Management Co., Ltd. have long been paying attention to the business of high-value consumables. In January 2019, they took the lead in investing in Zylox-Tonbridge and assisting the company to complete its business reshuffle. In 2020, they made a new round of investment in the company to support its rapid growth. SDIC Investment Management believes that Zylox-Tonbridge has the capability to gradually expand its product scopes on its current basis and commercialize more high quality medical products.